NCT00531635

Induction of Mixed Hemopoietic Chimerism in Patients Using Fludarabine, Low Dose TBI, PBSC Infusion and Post Transplant in Immunosuppression w/CSA & Mycophenolate Mofetil

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 350 (estimated)
• Sponsor: King Faisal Specialist Hospital & Research Center · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

Induction of mixed hemopoietic chimerism in patients using Fludarabine, Low Dose TBI, PBSC Infusion and post transplant in immunosuppression w/CSA \& Mycophenolate Mofetil

Conditions

• Post Transplant in Immunosuppression w/CSA & Mycophenolate Mofetil

Interventions

Type	Name	Description
DRUG	Mycophenolate Mofetil	Induction of Mixed Hemopoietic Chimerism in Patients Using Mycophenolate Mofetil

Timeline

• Start date: 2002-07-01
• Primary completion: 2012-06-01
• Completion: 2012-06-01
• First posted: 2007-09-19
• Last updated: 2011-12-13

Locations

1 site across 1 country: Saudi Arabia